Impact of Competition Versus Centralisation of Hospital Care on Process Quality: A Multilevel Analysis of Breast Cancer Surgery in France
Open Access
- 30 September 2020
- journal article
- research article
- Published by Maad Rayan Publishing Company in International Journal of Health Policy and Management
- Vol. 11 (4) , 459-469
Abstract
Background: The implications of competition among hospitals on care quality have been the subject of considerable debate. On one hand, economic theory suggests that when prices are regulated, quality will be increased in competitive markets. On the other hand, hospital mergers have been justified by the need to exploit cost advantages, and by evidence that hospital volume and care quality are related. Methods: Based on patient-level data from two years (2005 and 2012) we track changes in market competition and treatment patterns in breast cancer surgery. We focus on technology adoption as a proxy of process quality and examine the likelihood of offering two innovative surgical procedures: immediate breast reconstruction (IBR), after mastectomy and sentinel lymph node biopsy (SLNB). We use an index of competition based on a multinomial logit model of hospital choice which is not subject to endogeneity bias, and estimate its impact on the propensity to receive IBR and SLNB by means of multilevel models taking into account both observable patient and hospital characteristics. Results: The likelihood of receiving these procedures is significantly higher in hospitals located in more competitive markets. Yet, hospital volume remains a significant indicator of quality, therefore benefits of competition appear to be sensitive to the estimates of the impact of volume on care process. In France, the centralisation policy, with minimum activity thresholds, have contributed to improving breast cancer treatment between 2005 and 2012. Conclusion: Finding the right balance between costs and benefits of market competition versus concentration of hospital care supply is complex. We find that close to monopolistic markets do not encourage innovation and quality in cancer treatment, but highly competitive markets where many hospitals have very low activity volumes are also problematic because hospital quality is positively linked to patient volume.Keywords
This publication has 36 references indexed in Scilit:
- Do patients choose hospitals with high quality ratings? Empirical evidence from the market for angioplasty in the NetherlandsJournal of Health Economics, 2012
- Updating and Validating the Charlson Comorbidity Index and Score for Risk Adjustment in Hospital Discharge Abstracts Using Data From 6 CountriesAmerican Journal of Epidemiology, 2011
- Variation in management of early breast cancer in the Netherlands, 2003–2006European Journal of Surgical Oncology, 2010
- Regional variation in use of immediate breast reconstruction after mastectomy for breast cancer in EnglandEuropean Journal of Surgical Oncology, 2010
- Recent trends and predictors in immediate breast reconstruction after mastectomy in the United StatesThe American Journal of Surgery, 2009
- Diagnosis and treatment of early breast cancer, including locally advanced disease--summary of NICE guidanceBMJ, 2009
- Small Rural Hospitals and High-Risk Operations: How Would Regionalization Affect Surgical Volume and Hospital Revenue?Journal of the American College of Surgeons, 2006
- Confidence in the ability to communicate with physicians among low-income patients with prostate cancerUrology, 2004
- Competition, Payers, and Hospital Quality1Health Services Research, 2003
- Hospital Volume and Surgical Mortality in the United StatesNew England Journal of Medicine, 2002